TellerÃa, F.; Mansilla, S.; Méndez, D.; Sepúlveda, M.; Araya-Maturana, R.; Castro, L.; Trostchansky, A.; Fuentes, E.
The Use of Triphenyl Phosphonium Cation Enhances the Mitochondrial Antiplatelet Effect of the Compound Magnolol. Pharmaceuticals 2023, 16, 210.
https://doi.org/10.3390/ph16020210
AMA Style
TellerÃa F, Mansilla S, Méndez D, Sepúlveda M, Araya-Maturana R, Castro L, Trostchansky A, Fuentes E.
The Use of Triphenyl Phosphonium Cation Enhances the Mitochondrial Antiplatelet Effect of the Compound Magnolol. Pharmaceuticals. 2023; 16(2):210.
https://doi.org/10.3390/ph16020210
Chicago/Turabian Style
TellerÃa, Francisca, Santiago Mansilla, Diego Méndez, Magdalena Sepúlveda, Ramiro Araya-Maturana, Laura Castro, Andrés Trostchansky, and Eduardo Fuentes.
2023. "The Use of Triphenyl Phosphonium Cation Enhances the Mitochondrial Antiplatelet Effect of the Compound Magnolol" Pharmaceuticals 16, no. 2: 210.
https://doi.org/10.3390/ph16020210
APA Style
TellerÃa, F., Mansilla, S., Méndez, D., Sepúlveda, M., Araya-Maturana, R., Castro, L., Trostchansky, A., & Fuentes, E.
(2023). The Use of Triphenyl Phosphonium Cation Enhances the Mitochondrial Antiplatelet Effect of the Compound Magnolol. Pharmaceuticals, 16(2), 210.
https://doi.org/10.3390/ph16020210